Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Peter Bo Hansen"'
Autor:
Jesper Kjaergaard, Daniel A Steinbrüchel, Anh Thuc Ngo, Peter Bo Hansen, Christian Hassager, Lars Søndergaard, Peter Skov Olsen, M. Winther-Jensen, Hans Gustav Hørsted Thyregod, Nikolaj Ihlemann
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 19:39-46
Aims Patients with severe aortic stenosis (AS) can be considered for treatment with either transcatheter (TAVR) or surgical aortic valve replacement (SAVR). The purpose of this study was to compare left ventricular (LV) remodeling in patients with AS
Autor:
Hans Gustav Hørsted, Thyregod, Nikolaj, Ihlemann, Troels Højsgaard, Jørgensen, Henrik, Nissen, Bo Juel, Kjeldsen, Petur, Petursson, Yanping, Chang, Olaf Walter, Franzen, Thomas, Engstrøm, Peter, Clemmensen, Peter Bo, Hansen, Lars Willy, Andersen, Daniel Andreas, Steinbrüchel, Peter Skov, Olsen, Lars, Søndergaard
Publikováno v:
Circulation.
The Nordic Aortic Valve Intervention (NOTION) was designed to compare transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) in patients 70 years or older with isolated severe aortic valve stenosis. Clinical and ech
Autor:
Thomas Engstrøm, Henrik Nissen, Daniel A Steinbrüchel, Yanping Chang, Bo Juel Kjeldsen, Petur Petursson, Hans Gustav Hørsted Thyregod, Peter Bo Hansen, Peter Clemmensen, Lars Søndergaard, Lars Willy Andersen, Olaf Walter Franzen, Peter Skov Olsen, Troels H. Jørgensen, Nikolaj Ihlemann
Publikováno v:
Thyregod, H G H, Ihlemann, N, Jørgensen, T H, Nissen, H, Kjeldsen, B J, Petursson, P, Chang, Y, Franzen, O W, Engstrøm, T, Clemmensen, P, Hansen, P B, Andersen, L W, Steinbrüchel, D A, Olsen, P S & Søndergaard, L 2019, ' Five-Year Clinical and Echocardiographic Outcomes from the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk ', Circulation, vol. 139, no. 24, pp. 2714–2723 . https://doi.org/10.1161/CIRCULATIONAHA.118.036606
Background: The NOTION trial (Nordic Aortic Valve Intervention) was designed to compare transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) in patients ≥70 years old with isolated severe aortic valve stenosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294269a3199fb35d133478a60a0e79a0
https://portal.findresearcher.sdu.dk/da/publications/0e3ae4ee-7c3f-4c59-a9af-1432ed49bc68
https://portal.findresearcher.sdu.dk/da/publications/0e3ae4ee-7c3f-4c59-a9af-1432ed49bc68
Autor:
Peter Bo Hansen, Lars Søndergaard, Henrik Nissen, Peter Skov Olsen, Daniel A Steinbrüchel, Hans Gustav Hørsted Thyregod, Thuc Anh Ngo, Nikolaj Ihlemann, Bo Juel Kjeldsen, Yanping Chang
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 50:721-728
OBJECTIVES Prosthesis-patient mismatch (PPM) after surgical aortic valve replacement (SAVR) for severe aortic valve stenosis (AVS) is common, but less common after transcatheter aortic valve replacement (TAVR) in patients considered at high risk for
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis
Autor:
Hans Gustav Hørsted Thyregod, Bo Juel Kjeldsen, Petur Petursson, Peter Bo Hansen, Olaf Walter Franzen, Daniel A Steinbrüchel, Henrik Nissen, Yanping Chang, Peter Clemmensen, Lars Søndergaard, Lars Willy Andersen, Peter Skov Olsen, Nikolaj Ihlemann, Thomas Engstrøm
Publikováno v:
Journal of the American College of Cardiology. 65:2184-2194
BACKGROUND Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be safely introduced to lower-risk patients.
Autor:
Søren Boesgaard, Peter Bo Hansen, Jens C Nilsson, Finn Gustafsson, Joakim Cordtz, Kaare Sander, Peter Olesen
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 45:847-853
OBJECTIVES: Right ventricular failure (RVF) is a significant complication after implantation of a left ventricular assist device. We aimed to identify haemodynamic changes in the early postoperative phase that predicted subsequent development of RVF
Autor:
Jon M Appel, Peter Bo Hansen, Kåre Sander, Jacob E. Møller, Anders Krarup-Hansen, Finn Gustafsson
Publikováno v:
Congestive Heart Failure. 18:291-294
Anthracycline treatments are hampered by dose-related cardiotoxicity, frequently leading to heart failure (HF) with a very poor prognosis. The authors report a case of a 19-year-old man developing HF after anthracycline treatment for Ewing sarcoma. D
Autor:
Søren Boesgaard, Annette Schophuus Jensen, Finn Gustafsson, Per Lav Madsen, Jacob E. Møller, Peter Skov Olsen, Peter Bo Hansen, Niels H. Secher, Patrice Brassard, Christian Hassager, Kåre Sander, Nikolai Baastrup Nordsborg
Publikováno v:
Circulation: Heart Failure. 4:554-560
Background— End-stage heart failure is associated with impaired cardiac output (CO) and organ blood flow. We determined whether CO and peripheral perfusion are maintained during exercise in patients with an axial-flow left ventricular assist device
Autor:
Peter Bo Hansen, Tobias Bomholt, Søren Boesgaard, Peter Skov Olsen, Lars Køber, Claus Moser, Svend-Aage Mortensen, Finn Gustafsson, Kaare Sander
Publikováno v:
Scandinavian Cardiovascular Journal. 45:273-278
To investigate the incidence and outcome of driveline infections in patients supported with a continuous flow left ventricular assist device (HeartMate II (HMII)) and to study the microbiological aetiology.Retrospective analysis of 31 patients who re
Autor:
Kasper, Rossing, Mette Holme, Jung, Mette Holme, Junge, Kaare, Sander, Peter Skov, Olsen, Peter Bo, Hansen, Søren, Boesgaard, Finn, Gustafsson
Publikováno v:
Scandinavian cardiovascular journal : SCJ. 49(6)
Continuous-flow left ventricular assist devices like the HeartMate II (HMII) improves survival in severe heart failure but little is known about the incidence and causes of hospitalizations during long-term support which was evaluated in this study.O